Hypertension, Pregnancy Induced Clinical Trial
Official title:
Hydralazine vs. Labetalol for the Management of Hypertensive Crisis in Patients With Hypertensive Disorders of Pregnancy. A Randomized Controlled Trial.
Hypertensive crisis (defined as a systolic pressure > 160mmHg or a diastolic pressure > 110mmHg) in patients with a hypertensive disorder of pregnancy is a serious complication with severe and even deadly consequences. The management in this population had been studied, but no consensus has been reached with regards to which treatment is better. Our study will compare two drugs: Hydralazine and Labetalol for the management of hypertensive crisis.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01911494 -
Community Level Interventions for Pre-eclampsia
|
N/A | |
| Recruiting |
NCT06100484 -
Blood Pressure Variability Effect on Right Ventricular Strain in Women With Hypertensive Disorders With Pregnancy
|
||
| Completed |
NCT02050529 -
Randomized Controlled Trial of Labetalol Versus Hydralazine for Severe Hypertension in Obstetric Patients.
|
Phase 2 | |
| Recruiting |
NCT06069102 -
Optimal Blood Pressure Treatment Thresholds Postpartum
|
Phase 4 | |
| Recruiting |
NCT06281665 -
Treatment With Aspirin After Preeclampsia: TAP Trial
|
Phase 4 | |
| Not yet recruiting |
NCT05826925 -
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
|
N/A | |
| Not yet recruiting |
NCT05460416 -
Treatment Preventive for Pre-eclampsia by Acetylsalicylic Acid in Women Who Underwent Frozen Embryo Transfer
|
Phase 4 |